Value of infarct location in the prediction of functional outcome in patients with an anterior large vessel occlusion: results from the HERMES study.


Journal

Neuroradiology
ISSN: 1432-1920
Titre abrégé: Neuroradiology
Pays: Germany
ID NLM: 1302751

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 09 06 2021
accepted: 01 08 2021
pubmed: 4 9 2021
medline: 19 2 2022
entrez: 3 9 2021
Statut: ppublish

Résumé

Follow-up infarct volume (FIV) is moderately associated with functional outcome. We hypothesized that accounting for infarct location would strengthen the association of FIV with functional outcome. We included 252 patients from the HERMES collaboration with follow-up diffusion weighted imaging. Patients received endovascular treatment combined with best medical management (n = 52%) versus best medical management alone (n = 48%). FIV was quantified in low, moderate and high modified Rankin Scale (mRS)-relevant regions. We used binary logistic regression to study the relation between the total, high, moderate or low mRS-relevant FIVs and favorable outcome (mRS < 2) after 90 days. The strength of association was evaluated using the c-statistic. Small lesions only occupied high mRS-relevant brain regions. Lesions additionally occupied lower mRS-relevant brain regions if FIV expanded. Higher FIV was associated with a higher risk of unfavorable outcome, as were volumes of tissue with low, moderate and high mRS relevance. In multivariable modeling, only the volume of high mRS-relevant infarct was significantly associated with favorable outcome. The c-statistic was highest (0.76) for the models that included high mRS-relevant FIV or the combination of high, moderate and low mRS-relevant FIV but was not significantly different from the model that included only total FIV (0.75). This study confirms the association of FIV and unfavorable functional outcome but showed no strengthened association if lesion location was taken into account.

Identifiants

pubmed: 34476512
doi: 10.1007/s00234-021-02784-x
pii: 10.1007/s00234-021-02784-x
pmc: PMC8850210
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

521-530

Subventions

Organisme : Medical Research Council
ID : MR/N003403/1
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s).

Références

Interv Neurol. 2018 Oct;7(6):533-543
pubmed: 30410533
J Neurol Neurosurg Psychiatry. 2017 Jan;88(1):38-44
pubmed: 27756804
Sci Rep. 2018 Jun 22;8(1):9498
pubmed: 29934530
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
Emerg Radiol. 2018 Dec;25(6):659-672
pubmed: 29980872
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):E4367-76
pubmed: 27402738
Neuroimage. 2008 Feb 1;39(3):1064-80
pubmed: 18037310
Stroke. 2014 Jun;45(6):1695-702
pubmed: 24781084
Neuroimaging Clin N Am. 2005 Aug;15(3):553-73, x
pubmed: 16360589
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
J Neurointerv Surg. 2018 Dec;10(12):1137-1142
pubmed: 29627794
Stroke. 2016 Jan;47(1):66-73
pubmed: 26585396
Stroke. 1998 Sep;29(9):1778-82
pubmed: 9731594
Lancet Neurol. 2016 Oct;15(11):1138-47
pubmed: 27567239
Biol Psychiatry. 2007 Apr 15;61(8):935-45
pubmed: 17046727
Cerebrovasc Dis. 2005;19(4):239-46
pubmed: 15741718
Stroke. 2020 Oct;51(10):3147-3155
pubmed: 32933417
Schizophr Res. 2006 Apr;83(2-3):155-71
pubmed: 16448806
Stroke. 2015 Sep;46(9):2438-44
pubmed: 26199314
Arch Neurol. 2003 Mar;60(3):351-5
pubmed: 12633146
Stroke. 2016 Jun;47(6):1459-65
pubmed: 27217502
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Am J Psychiatry. 2005 Jul;162(7):1256-65
pubmed: 15994707
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Stroke. 2016 May;47(5):1389-98
pubmed: 27073243
Stroke. 2017 Sep;48(9):2426-2433
pubmed: 28765288

Auteurs

Manon L Tolhuisen (ML)

Department of Biomedical Engineering and Physics, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands. m.l.tolhuisen@amsterdamumc.nl.
Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands. m.l.tolhuisen@amsterdamumc.nl.

Marielle Ernst (M)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Göttingen, Göttingen, Germany.

Anne M M Boers (AMM)

Nico.Lab, www.nico-lab.com, Amsterdam, The Netherlands.

Scott Brown (S)

Altair Biostatistics, St Louis Park, MN, USA.

Ludo F M Beenen (LFM)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.

Francis Guillemin (F)

CIC-Epidémiologie Clinique, 1433, Inserm, CHRU, Université de Lorraine, Nancy, France.

Yvo B W E M Roos (YBWEM)

Department of Neurology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.

Jeffrey L Saver (JL)

Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.

Robert van Oostenbrugge (R)

Department of Neurology, Maastricht UMC, Maastricht, The Netherlands.
Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.

Andrew M Demchuck (AM)

Department of Clinical Neurosciences, Department of Radiology and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Wim van Zwam (W)

Department of Radiology, Maastricht UMC, Maastricht, The Netherlands.

Tudor G Jovin (TG)

Department of Neurology, Stroke Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Olvert A Berkhemer (OA)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Keith W Muir (KW)

Institute of Neuroscience and Psychology, University of Glasgow, University Avenue, Glasgow, UK.

Serge Bracard (S)

CIC-Epidémiologie Clinique, 1433, Inserm, CHRU, Université de Lorraine, Nancy, France.
Department of Diagnostic and Interventional Neuroradiology, IADI, Inserm, CHRU, Université de Lorraine, Nancy, France.

Bruce C V Campbell (BCV)

Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.
Department of Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Aad van der Lugt (A)

Institute of Neuroscience and Psychology, University of Glasgow, University Avenue, Glasgow, UK.

Phill White (P)

Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Department of Neuroradiology, Newcastle upon Tyne hospitals, Newcastle upon Tyne, UK.

Michael D Hill (MD)

Department of Clinical Neurosciences, Department of Radiology and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Community Health Sciences, O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
Department of Radiology, Cumming School of Medicine, University of Calgary & Foothills Medical Centre, Calgary, Alberta, Canada.
Department of Medicine, Cumming School of Medicine, University of Calgary & Foothills Medical Centre, Calgary, Calgary, Canada.

Diederik W J Dippel (DWJ)

Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Peter J Mitchell (PJ)

Department of Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Mayank Goyal (M)

Department of Clinical Neurosciences, Department of Radiology and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Matthan W A Caan (MWA)

Department of Biomedical Engineering and Physics, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.

Henk A Marquering (HA)

Department of Biomedical Engineering and Physics, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.

Charles B L M Majoie (CBLM)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH